Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > Oh oh.
View:
Post by boazklinghorn on May 03, 2023 11:12am

Oh oh.

If only the idea of the game was to find interesting preliminary tidbits in the lab, CZO would be a world beater. Yet another bit of PGX potentiality. The real news is coming up in a week or two and the will be not what could or might happen  but what in fact did happen and that is the only important criterian. I have noticed that Gilles and Jenene have a tell. They will put out an inconsequential bit of good news if the pending consequential news is not going to be great. We shall see.
Comment by Ciao on May 03, 2023 11:52am
It does appear that way at times, but they did have news before Q1 2022 and Q2 2022 was released and those results were good.
Comment by prophetoffactz on May 03, 2023 1:25pm
We had already seen the wound healing scientific abstract. We saw it the day the news release about the coming presentation was released. The data many haven't seen is for fibrosis. Around the time of the Q1 financials there should be a news release about the fibrosis presentation which is May 19-24. That data could support a Phase I clinical trial this summer and PGX-YBG as a stand alone ...more  
Comment by Hopeforthebest on May 03, 2023 2:42pm
The fact of the matter is gagnon has and will continue to miss the boat falling behind on product delivery and communications. The results in more missed opportunity and more delays. gagnon is cost us and CZO MONEY with is inability to hit when the iron is hot he can manage the business of the company effectively. Money in the bank means absolutely diddly squay when it just lies there loosing ...more  
Comment by prophetoffactz on May 03, 2023 11:56am
"The real news is coming up in a week or two and the will be not what could or might happen  but what in fact did happen and that is the only important criterian." The base business is a business that has grown at approximately a double digit rate for a decade despite at times considerable quarter-to-quarter variability depending on what quarter an order is filled and supply-chain ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities